Literature DB >> 9215873

Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis.

K Hastak1, N Lubri, S D Jakhi, C More, A John, S D Ghaisas, S V Bhide.   

Abstract

In vitro studies on the effect of alcoholic extracts of turmeric (TE), turmeric oil (TO) and turmeric oleoresin (TOR), on the incidence of micronuclei (Mn) in lymphocytes from normal healthy subjects showed that the test compounds did not cause any increase in the number of Mn as compared with those found in untreated controls. Further it was observed that all three compounds offered protection against benzo[a]pyrene induced increase in Mn in circulating lymphocytes. In subsequent studies, patients suffering from submucous fibrosis were given a total oral dose of TO (600 mg TO mixed with 3 g TE/day). TOR (600 mg + 3 g TE/day) and 3 g TE/day as a control for 3 months. It was observed that all three treatment modalities decreased the number of micronucleated cells both in exfoliated oral mucosal cells and in circulating lymphocytes. TOR was found to be more effective in reducing the number of Mn in oral mucosal cells (P < 0.001), but in circulating lymphocytes the decrease in Mn was comparable in all three groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215873     DOI: 10.1016/s0304-3835(97)00205-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

Review 1.  Proposed clinical definition for oral submucous fibrosis.

Authors:  Chandramani B More; Naman R Rao
Journal:  J Oral Biol Craniofac Res       Date:  2019-07-02

Review 2.  Therapeutic roles of curcumin: lessons learned from clinical trials.

Authors:  Subash C Gupta; Sridevi Patchva; Bharat B Aggarwal
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

Review 3.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

4.  Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa.

Authors:  Grace G L Yue; Ben C L Chan; Po-Ming Hon; Mavis Y H Lee; Kwok-Pui Fung; Ping-Chung Leung; Clara B S Lau
Journal:  Food Chem Toxicol       Date:  2010-05-09       Impact factor: 6.023

5.  Use of Curcuma longa L. extract to stain various tissue samples for histological studies.

Authors:  Sachin Kumar; Narendra Nath Singh; Arun Singh; Neelakshi Singh; Raman Kant Sinha
Journal:  Ayu       Date:  2014 Oct-Dec

6.  Safety evaluation of turmeric polysaccharide extract: assessment of mutagenicity and acute oral toxicity.

Authors:  Chandrasekaran Chinampudur Velusami; Srinivasa Rao Boddapati; Srikanth Hongasandra Srinivasa; Edwin Jothie Richard; Joshua Allan Joseph; Murali Balasubramanian; Amit Agarwal
Journal:  Biomed Res Int       Date:  2013-12-17       Impact factor: 3.411

7.  Cytologic follow up of Low-grade Squamous Intraepithelial Lesions in Pap smears after integrated treatment with antimicrobials followed by oral turmeric oil extract.

Authors:  Jayashree Vinay Joshi; Sujata S Jagtap; Prajakta Hemant Paradkar; Priya Walwatkar; Hemant S Paradkar; Zubair M Affandi; Ashok D B Vaidya
Journal:  J Ayurveda Integr Med       Date:  2016-07-27

8.  Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model.

Authors:  Preeti Dohare; Puja Garg; Uma Sharma; N R Jagannathan; Madhur Ray
Journal:  BMC Complement Altern Med       Date:  2008-09-30       Impact factor: 3.659

9.  Pathogenesis and therapeutic intervention of oral submucous fibrosis.

Authors:  Thukanaykanpalayam Ragunathan Yoithapprabhunath; Thangadurai Maheswaran; Janardhanam Dineshshankar; Abraham Anusushanth; Pandian Sindhuja; Govindasamy Sitra
Journal:  J Pharm Bioallied Sci       Date:  2013-06

10.  Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma.

Authors:  Yan Li; Xue Shi; Jingwen Zhang; Xiang Zhang; Robert C G Martin
Journal:  Int J Oncol       Date:  2013-11-21       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.